NPM1 and acute myeloid leukemia: Of the two studies that showed the adverse prognostic significance of the IDH1 c.315C>T SNP, one (10) (N=51, 8 with variant) reported that the SNP confers an inferior prognosis in NPM1/CEBPA wild-type Egyptian patients with AML.